Alexion Pharmaceuticals (United States)

Alexion Pharmaceuticals (United States)

Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alexion Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

56%


Total
Publications

980


Total Open
Publications

550


Total
Citations

36K


Open Access
Percentage

56%


Total
Publications

980


Total Open
Publications

550


Total
Citations

36K

Wikipedia

Website

download

Breakdown

20% 32% 4% 44%

Publisher Open

20%

Both

32%

Other Platform Open

4%

Closed

44%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

42%OA Journal

OA Journal 42%

210

Hybrid 35%

178

No Guarantees 23%

115

Other Platform Open

Domain 82%

288

Institution 31%

108

Other Internet 14%

48

Public 2%

6

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
291
DOI
Other Internet
36
DANS - Data Archiving and Networked Services
Institution
28
Europe PMC
Domain
17
Elsevier - Scopus
Institution
15
Unknown Repository
Other Internet
12
Ghent University - Ghent University Academic Bibliography
Institution
11
Sapienza University of Rome - IRIS Research product catalog
Institution
9
Universidad Autónoma de Madrid - Biblos-e Archivo
Institution
8
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
8
1 / 7

Data updated 18 August 2025

Share

Share

Share